Infinity Bio is a biotech company that offers analytics and insight services for antibody reactome profiling against all human viruses.
Infinity Bio has raised $8.0M in total funding. The most recent round was Series A. The last funding was announced in June 2025.
Infinity Bio's investors include Illumina Ventures, PTX Capital, Blackbird BioVentures, Propel Baltimore Fund.
Infinity Bio is headquartered in Baltimore, United States.
Infinity Bio is a biotech company that offers analytics and insight services for antibody reactome profiling against all human viruses.
Infinity Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Infinity Bio — Funding & Investors." VCBacked, June 18, 2025, https://www.vcbacked.co/company/infinity-bio. Accessed August 13, 2026.
VCBacked. (2025). Infinity Bio — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/infinity-bio
{{cite web |title=Infinity Bio — Funding & Investors |url=https://www.vcbacked.co/company/infinity-bio |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated